We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inflammatory Marker Levels Established In Specific Obese Adolescents

By LabMedica International staff writers
Posted on 21 Mar 2012
Print article
Levels of inflammatory biomarkers in the blood have been measured in obese adolescents who are glucose intolerant and possibly prediabetic.

Increased levels of systemic inflammatory markers, such as C-reactive protein (CRP), the cytokine interleukin-6 (IL-6) and elevated pteridine derivatives as well as specific enzyme levels may be influenced by glucose intolerance.

At the Ege University, (Izmir, Turkey) scientists performed oral glucose tolerance tests (OGTT) on 45 pubertal obese children, 23 girls and 22 boys with a mean age of 13.52 years. Biochemical analyses were performed on the sample collection day, that included glucose, insulin, glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein AI (Apo A), apolipoprotein B100 (Apo B), CRP, IL-6, neopterin levels, complete blood count and chitotriosidase activities. Serum chitotriosidase activity was measured by a fluorescence method and fasting serum concentrations of IL-6 and neopterin were determined by the use of commercial enzyme-linked immunosorbent assays (ELISA).

In 21 children, normal glucose tolerance (NGT) was observed being defined as fasting glucose levels of less than 5.6 mmol/L and two hour glucose levels of less than 7.8 mmol/L. Impaired glucose tolerance (IGT) was found in 24 children where after the OGTT, the two hour glucose levels were between 7.8 and 11.1 mmol/L. The IL-6 and CRP levels were similar in the two groups. There was no significant difference in the lipid profiles or serum neopterin levels between the groups. However, the chitotriosidase activity was significantly higher in the IGT group at 124.33 ± 51.97 μmol/L/hour than the NGT group where the mean activity was 84.50 ± 53.99 μmol/L/hour. The chitotriosidase activity was measured on the F-2500 fluorometer (Hitachi Ltd., Tokyo, Japan). The fasting serum concentrations of IL-6 was determined by the ELISA kit from DIA Source (Louvain-La-Neuve, Belgium) and neopterin levels with an ELISA from DRG Instruments, (Marburg, Germany).

Activated macrophages secrete several proteins, like neopterin and chitotriosidase, which could influence the atherosclerotic process, leading to a local inflammation in the vessel wall. The authors concluded that the results of their study show that serum chitotriosidase activity is increased in obese adolescents with impaired glucose tolerance. Impaired glucose tolerant state is an important period in which atherosclerotic lesions start to emerge. The results demonstrate that the existence of glucose intolerance may aggravate the local inflammation, which mainly occurs in the vascular bed in obese children. The study was published in the March 2012 issue of the journal Clinical Biochemistry.

Related Links:
Ege University
Hitachi Ltd.
DIA Source



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.